Park Ha Biological Technology Co. Ltd. Class A Ordinary Shares (BYAH)

FairStock Score: 45/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for a durable business that earns good returns on capital and is priced sensibly. Park Ha sells skincare in China through directly operated stores and franchisees, with only 41 employees and a $3.4M market cap at the 2026-10-13 close of $2.37. That is a tiny operation in a competitive consumer category, and I see no evidence of a moat. The financials are poor: FairStock calculates a P/E of -0.06, ROE of -113.04%, ROCE of -50.74%, and a P/B of 0.27. The negative earnings mean the P/B discount is not a margin of safety by itself; book value can shrink. The Piotroski F-Score is 0/9 and the Altman Z-Score is -3.90, which point to financial distress rather than strength. The only clear balance-sheet positive is low leverage: D/E of 0.03. Growth is impossible to judge because the data shows no revenue or profit growth figures, and the Lynch category is none, with only 0 years of filed results where at least 3 are needed. The 52-week range of $0.32 to $21.20 signals extreme speculation. At $2.37, the stock may look cheap against book value, but a negative P/E and deeply negative returns say the business is not currently earning its cost of capital. I would need a multi-year record of positive owner earnings and stable finances before calling this anything other than a speculative turnaround. FairStock Score 45/100 seems generous relative to the numbers.

In plain English: Park Ha Biological Technology is a small Chinese skincare company that sells through its own stores and franchisees. The business looks weak because it is losing money and its returns are negative. The share price is very low compared with its accounting value, so it looks cheap, but that cheapness may just reflect the losses.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer